Sotera Health Company (SHC)

Sotera Health Company Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,216	1,164	1,100	1,049	1,004	931.48
Revenue Growth	8.15%	5.74%	4.88%	4.54%	7.75%	13.85%
Gross Profit Gross Profit Growth	668.51	645.53	602.3	577.16	557	518.67
Operating Income Operating Income Growth	448.99	414.33	335.51	326.99	327.89	305.53
Net Income Net Income Growth	163.48	77.95	44.34	51.09	-233.57	115.36
Earnings Per Share EPS Growth	0.57	0.27	0.16	0.18	-0.83	0.41
EPS Growth	570.85%	72.20%	-12.89%	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Sterigenics Sterigenics Growth	788.96	755.78	697.85	667.13	626.65	571.83
Nordion Nordion Growth	203.79	187.62	173.36	160.46	153.64	140.51
Nelson Labs Nelson Labs Growth	223.42	220.22	229.23	221.7	223.4	219.14
Revenue (Total) Revenue (Total) Growth	1,216	1,164	1,100	1,049	1,004	931.48

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	356.95	344.9	278.05	297.12	395.87	107.54
Total Debt Total Debt Growth	2,268	2,276	2,351	2,327	2,032	1,828
Net Cash (Debt) Net Cash Growth	-1,911	-1,931	-2,073	-2,030	-1,636	-1,720
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-6.62	-6.74	-7.27	-7.17	-5.84	-6.16

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	292.19	287.2	224.16	-147.73	277.96	281.55
Capital Expenditures CapEx Growth	-179.49	-138.02	-179.07	-214.98	-182.38	-102.16
Free Cash Flow Free Cash Flow Growth	112.7	149.18	45.09	-362.71	95.58	179.38
Free Cash Flow Growth	0.00%	230.81%	-	-	-46.72%	167.42%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	54.97%	55.48%	54.73%	55.01%	55.50%	55.68%
Operating Margin	36.92%	35.61%	30.49%	31.16%	32.67%	32.80%
Pretax Margin	21.72%	12.68%	10.35%	10.10%	-24.22%	18.86%
Profit Margin	13.44%	6.70%	4.03%	4.87%	-23.27%	12.38%
FCF Margin	9.27%	12.82%	4.10%	-34.57%	9.52%	19.26%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	32.32	64.29	87.39	93.21	-	57.76
Forward PE	17.90	19.12	18.03	18.81	8.38	24.18
P/FCF Ratio	46.52	33.59	85.93	-	24.59	37.14
PS Ratio	4.31	4.31	3.52	4.54	2.34	7.15

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error